首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients
【24h】

Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients

机译:液相色谱-电喷雾串联质谱法测定人血浆中的齐拉西酮及其在精神分裂症患者血浆中的含量测定

获取原文
获取原文并翻译 | 示例
           

摘要

An accurate, rapid and simple liquid chromatography-tandem mass spectrometry (LC-MS-MS) assay method was developed for the determination of ziprasidone (ZIP) in the plasma of schizophrenia patients. A simple one step liquid-liquid extraction with 20% methylene dichloride in pentane was used to isolate ZIP and the internal standard from the plasma matrix. The compounds were separated on a C-18 column by an isocratic elution and the eluted compounds were analyzed by a triple quadrupole mass spectrometer with a Turbolon spray interface using the positive ion atmospheric pressure electrospray ionization method and detected using multiple reaction monitoring mode. The ZIP standard calibration curve was linear over the range of 0.25-500 ng/ml when 0.5 ml of plasma was used for the analysis (r(2) > 0.998). The intra-assay (within-day) and inter-assay (between-day) variations were less than 12% for the spiked standard curve and quality control samples. The absolute extraction efficiency was 82% for ZIP and 68% for INS-RSP. The analysis time for each sample was less than 3 min and useful for high turnaround plasma level determinations. This LC-MS-MS assay method for ZIP is highly specific, sensitive, accurate and rapid and is currently being used for the plasma level determination of ZIP in schizophrenia patients treated with various daily oral doses of ZIP. The data showed large inter-individual variations. (c) 2006 Elsevier B.V. All rights reserved.
机译:建立了一种准确,快速,简便的液相色谱-串联质谱(LC-MS-MS)测定方法,用于测定精神分裂症患者血浆中的齐拉西酮(ZIP)。使用在戊烷中的20%二氯甲烷进行的简单一步液-液萃取,从血浆基质中分离ZIP和内标。通过等度洗脱在C-18柱上分离化合物,并使用正离子大气压电喷雾电离方法通过具有Turbolon喷雾界面的三重四极杆质谱仪分析洗脱的化合物,并使用多反应监测模式进行检测。当使用0.5 ml血浆进行分析时,ZIP标准校准曲线在0.25-500 ng / ml的范围内呈线性(r(2)> 0.998)。对于加标的标准曲线和质量控制样品,测定内(日内)和测定间(日间)变化小于12%。 ZIP的绝对提取效率为82%,INS-RSP的绝对提取效率为68%。每个样品的分析时间少于3分钟,可用于高周转血浆水平测定。这种针对ZIP的LC-MS-MS分析方法具有高度特异性,灵敏性,准确性和快速性,目前正用于测定每天口服各种ZIP剂量的精神分裂症患者的血浆ZIP水平。数据显示个体间差异很大。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号